Prostate Cancer, An Issue of Urologic Clinics

著者名：Bjurlin DO, Marc A./Taneja MD, Samir S.

Elsevier（2017/11/06発売）

• 言語：ENG
• ISBN：9780323549059
• eISBN：9780323549066

Description

Dr. Samir Taneja, Consulting Editor, is stepping into the Guest Editor role for this issue of Urologic Clinics devoted to Prostate Cancer. He has assembled top experts to address the latest advances in the diagnosis and treatment of prostate cancer. Articles are devoted to the following topics: Whom to Biopsy: Pre-Diagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators; How to Biopsy: Transperineal vs. Tranrectal, Saturation vs. Targeted: What's the Evidence; Pre-Diagnostic Risk and Assessment with Imaging and Image-guided Biopsy; Whom to treat: Post-Diagnostic Risk Assessment with Gleason score, Risk Models, and Genomic Classifier; Strategies for Staging and Utilization of Imaging; Contemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected Outcomes; Focal Ablation of Early Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome; Extent of Lymphadenectomy at Time of Prostatectomy: An Evidence-based Approach; How to Radiate the Prostate: Hypofractionation, Sterotactic Body Radiation Therapy, and Conventional Intensity-Modulated Radiotherapy; Managing Relapse after Surgical Therapy: Adjuvant vs. Salvage Therapy; Newly diagnosed Metastatic Prostate Cancer – Has the Paradigm Changed; Role of Local therapy in Oligometastatic Prostate Cancer: Should we Expect Cure; Approaching the High-Risk Patient; and Castration-Resistant Prostate Cancer: An Algorithmic Approach. Readers will come away with state-of-the-art information on strategies for diagnosing, treating, and managing prostate cancer.

Table of Contents

Urologic Clinics of North AmericaProstate CancerPreface: Prostate CancerWhom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk CalculatorsHow to Biopsy: Transperineal Versus Transrectal, Saturation Versus Targeted, What's the Evidence?Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted BiopsyWhom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic ClassifierGallium–Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate CancerContemporary Active Surveillance: Candidate Selection, Follow-up Tools, and Expected OutcomesFocal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of OutcomeExtent of Lymphadenectomy at Time of Prostatectomy: An Evidence-Based ApproachManaging Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation TherapyNewly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a CureApproach to the Patient with High-Risk Prostate CancerCastration-Resistant Prostate Cancer: An Algorithmic Approach